Company Aarti Pharmalabs Limited

AARTIPHARM

INE0LRU01027

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 12:58:32 07/06/2024 BST			5-day change	1st Jan Change
602.4 ^INR	+2.48%		+7.18%	+19.41%

05-14	GRIFOLS SHARES DOWN 4.8% AFTER GOTHAM CITY RESEARCH ISSUES REPOR…	RE
05-13	Aarti Pharmalabs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Aarti Pharmalabs Limited is a manufacturer of active pharmaceutical ingredients (API), pharmaceutical intermediates, new chemical entities (NCE), xanthine derivatives, and allied products, situated in India. The Company delivers contract development and manufacturing organization (CDMO) services for drug substance/NCE development and manufacturing for pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of corticosteroids, cytotoxic medicines, and oncology products. Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its range of intermediate products include Abemaciclib Intermediate, Acalabrutinib Intermediate, Afatinib Intermediate, Apalutamide Intermediate, Azathioprine Intermediate, and others. Its Caffeine products include caffeine anhydrous, and caffeine anhydrous (granules).

Number of employees: 2,042

INR in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical and Related Products 100.0 %	-	-	19,452	100.0 %	-

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	0	nan %	19,452	100.0 %	-

Managers	Title	Age	Since
Narendra Jagannath Salvi CEO	Chief Executive Officer	59	16/10/22
Hetal Gogri Gala CEO	Chief Executive Officer	48	16/10/22
Piyush Lakhani DFI	Director of Finance/CFO	-	16/10/22
Nikhil Natu CMP	Compliance Officer	-	-

Members of the board	Title	Age	Since
Hetal Gogri Gala CEO	Chief Executive Officer	48	16/10/22
Rashesh Chandrakant Gogri CHM	Chairman	50	06/08/21
Chandrakant V. Gogri BRD	Director/Board Member	77	-
Rajendra Vallabhaji Gogri BRD	Director/Board Member	64	-
Parimal Hasmukhlal Desai BRD	Director/Board Member	75	-
Vilas Gajanan Gaikar BRD	Director/Board Member	63	-
Bhavesh Rasiklal Vora BRD	Director/Board Member	56	-
Vinay Gopal Nayak BRD	Director/Board Member	67	-
Rupal Anand Vora BRD	Director/Board Member	61	-
Narendra Jagannath Salvi CEO	Chief Executive Officer	59	16/10/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	90,626,008	47,193,340 ( 52.07 %)	0	52.07 %

Name	Equities	%	Valuation
Rashesh Chandrakant Gogri 4.231 %	3,834,404	4.231 %	24 M ₹
Anushakti Enterprise Private Ltd. 3.254 %	2,949,200	3.254 %	18 M ₹
Mirik Rajendra Gogri 3.082 %	2,793,094	3.082 %	17 M ₹
Renil Rajendra Gogri 3.082 %	2,792,750	3.082 %	17 M ₹
Hetal Gogri Gala 2.886 %	2,615,548	2.886 %	16 M ₹
Jaya Chandrakant Gogri 2.731 %	2,474,637	2.731 %	15 M ₹
Sarla Shantilal Shah 2.688 %	2,435,830	2.688 %	15 M ₹
Labdhi Business Trust 2.538 %	2,300,000	2.538 %	14 M ₹
quant Money Managers Ltd. 2.078 %	1,883,371	2.078 %	12 M ₹
Tulip Family Trust 1.820 %	1,649,000	1.820 %	10 M ₹

Aarti Pharmalabs Ltd.

Embassy Park 247 LBS Marg, Vikhroli West

400083, Mumbai

+91 22 6797 6666

http://www.aartipharmalabs.com

address Aarti Pharmalabs Limited(AARTIPHARM)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
AARTI PHARMALABS LIMITED	+19.41%	654M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
NOVARTIS AG	+11.88%	216B
ROCHE HOLDING AG	-0.78%	219B
AMGEN INC.	+5.90%	164B

Other Pharmaceuticals